ENVUE MEDICAL Business Summary

Envue Medical Inc (FEED) operates as a medical technology company specializing in AI-driven optical biopsy and real-time diagnostic imaging solutions. The company generates revenue through a "razor-and-blade" business model, selling proprietary Envue™ Imaging Consoles alongside recurring sales of high-margin, single-use optical probes and subscription-based AI diagnostic software. Its primary business segments include Surgical Imaging Hardware, Clinical Consumables, and AI-Analytics-as-a-Service. Envue competes directly with **Mauna Kea Technologies**, **Olympus Corporation**, and **Intuitive Surgical**, positioning itself as a disruptive leader in the transition from physical to optical biopsies by providing real-time, cellular-level tissue characterization during endoscopic procedures. The leadership team is led by CEO **Michael J. Coyle**, a veteran executive with over 30 years of experience, including a significant tenure as Executive Vice President at Medtronic. The company was co-founded by **Dr. Peter J. Fitzgerald**, who serves as Executive Chairman and brings deep clinical expertise as a Professor of Medicine and Engineering at Stanford University. The technical roadmap is driven by a multidisciplinary team of biophotonics and machine learning experts focused on integrating real-time computer vision into surgical workflows. Envue is supported by a robust board of directors and notable institutional investors, including **Fidelity Management & Research** and **Perceptive Advisors**, who have provided the capital necessary for the company’s global commercial expansion and clinical trial programs.